SIR-Spheres® Y-90 Resin Microspheres in Chemotherapy Refractory or Intolerant Patients With Metastatic Colorectal Cancer

Global and Regional Health Technology Assessment - Italy
doi 10.1177/2284240319847446
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Aboutscience Srl

Related search

Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: A UK Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: An Italian Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

A Single Institute Retrospective Trial of Concurrent Chemotherapy With SIR-Spheres® Versus SIR-Spheres® Alone in Chemotherapy-Resistant Colorectal Cancer Liver Metastases

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Reolysin® Enters Clinical Trial for Patients With Metastatic Colorectal Cancer

Immunotherapy
OncologyAllergyImmunology
2009English

Health-Related Quality of Life and Colorectal Cancer-Specific Symptoms in Patients With Chemotherapy-Refractory Metastatic Disease Treated With Panitumumab

International Journal of Colorectal Disease
Gastroenterology
2010English

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Die Transarterielle Radioembolisation Von Leberkarzinomen Mit Y-90-Harzsphären (SIR-Spheres)

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2010English

Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy